Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shelley Crary

Concepts (180)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vascular Malformations
9
2025
105
3.950
Why?
Blood Coagulation Disorders
4
2022
41
2.450
Why?
Kasabach-Merritt Syndrome
3
2024
5
1.800
Why?
Splenectomy
10
2018
36
1.540
Why?
Hemostasis
2
2024
55
1.470
Why?
Spherocytosis, Hereditary
6
2015
14
1.360
Why?
Sclerotherapy
3
2022
47
1.330
Why?
Hemangioendothelioma
3
2024
8
1.160
Why?
Hemophilia A
2
2024
27
0.900
Why?
Sarcoma, Kaposi
2
2023
77
0.870
Why?
Anticoagulants
3
2024
280
0.840
Why?
Anemia, Sickle Cell
6
2025
105
0.840
Why?
Child
29
2025
7384
0.820
Why?
Child, Preschool
22
2025
4164
0.780
Why?
Thrombosis
2
2024
250
0.760
Why?
Purpura, Thrombocytopenic, Idiopathic
4
2025
26
0.720
Why?
Thrombelastography
1
2020
27
0.650
Why?
Sirolimus
2
2023
72
0.620
Why?
Adolescent
23
2025
6912
0.620
Why?
Bleomycin
2
2022
38
0.580
Why?
Autoimmune Lymphoproliferative Syndrome
1
2018
2
0.560
Why?
Antibiotics, Antineoplastic
1
2018
84
0.510
Why?
Humans
41
2025
53246
0.490
Why?
Young Adult
12
2024
4514
0.480
Why?
Hemorrhage
5
2025
226
0.460
Why?
Female
26
2025
28792
0.460
Why?
Postoperative Complications
3
2014
1099
0.450
Why?
Male
26
2025
27444
0.450
Why?
Hematology
2
2025
23
0.440
Why?
Hematinics
2
2013
15
0.430
Why?
Reticulocyte Count
2
2015
4
0.430
Why?
Anemia, Iron-Deficiency
2
2013
24
0.420
Why?
Adult
15
2025
14541
0.420
Why?
Heart Transplantation
1
2018
327
0.410
Why?
Infant
13
2025
3808
0.410
Why?
Factor IX
2
2024
2
0.410
Why?
Hemophilia B
2
2024
5
0.410
Why?
Genetic Therapy
2
2024
127
0.370
Why?
Hematologic Diseases
2
2009
21
0.370
Why?
Ferric Compounds
1
2010
16
0.330
Why?
Retrospective Studies
11
2024
6821
0.310
Why?
Hypertension, Pulmonary
1
2011
102
0.310
Why?
Vascular Diseases
2
2009
75
0.300
Why?
Blood Flow Velocity
2
2020
99
0.290
Why?
Enoxaparin
1
2008
32
0.280
Why?
Prospective Studies
7
2025
2412
0.250
Why?
Administration, Oral
3
2025
456
0.250
Why?
Thromboembolism
1
2006
48
0.240
Why?
Receptors, Thrombopoietin
1
2025
5
0.230
Why?
Hydrazines
1
2025
19
0.230
Why?
Benzoates
1
2025
22
0.230
Why?
Treatment Outcome
7
2025
5597
0.230
Why?
Venous Thrombosis
1
2006
91
0.230
Why?
Risk Factors
5
2024
4018
0.220
Why?
Cardiovascular Diseases
1
2010
501
0.220
Why?
Osteomyelitis
1
2006
134
0.220
Why?
Pyrazoles
1
2025
123
0.210
Why?
Hemoglobins
4
2015
114
0.210
Why?
Postoperative Hemorrhage
1
2024
54
0.210
Why?
Professional Role
1
2024
85
0.210
Why?
Factor VIII
1
2024
24
0.210
Why?
Middle Aged
9
2025
13422
0.200
Why?
von Willebrand Diseases
1
2024
24
0.200
Why?
Vascular Neoplasms
1
2023
17
0.200
Why?
Anemia, Hemolytic, Congenital
2
2014
4
0.200
Why?
Autoantibodies
1
2024
120
0.200
Why?
Critical Illness
2
2020
316
0.190
Why?
Hemangioma
1
2023
86
0.190
Why?
Attitude of Health Personnel
1
2025
371
0.180
Why?
Parents
1
2025
341
0.180
Why?
Pupil
1
2021
28
0.180
Why?
Databases, Factual
2
2024
742
0.170
Why?
Acute Pain
1
2021
12
0.170
Why?
Patient Acceptance of Health Care
1
2025
379
0.170
Why?
Infusions, Intravenous
3
2013
211
0.170
Why?
Health Knowledge, Attitudes, Practice
1
2025
523
0.170
Why?
Mental Health
1
2024
249
0.170
Why?
Anxiety
1
2024
321
0.170
Why?
Arterial Occlusive Diseases
1
2021
85
0.160
Why?
Blood Coagulation Tests
1
2020
18
0.160
Why?
Platelet Count
3
2025
68
0.160
Why?
Multiple Organ Failure
1
2020
51
0.160
Why?
Blood Coagulation
1
2020
65
0.160
Why?
Cross-Sectional Studies
3
2025
1723
0.150
Why?
Antibodies, Monoclonal, Humanized
1
2021
238
0.150
Why?
Pain
2
2021
353
0.150
Why?
Klippel-Trenaunay-Weber Syndrome
1
2019
3
0.150
Why?
Thrombopoietin
1
2019
9
0.150
Why?
Receptors, Fc
1
2019
10
0.150
Why?
Vitiligo
1
2019
8
0.140
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.140
Why?
Leukoencephalopathies
1
2019
15
0.140
Why?
Nervous System Malformations
1
2019
17
0.140
Why?
Depression
1
2024
621
0.140
Why?
Skin Neoplasms
1
2023
500
0.140
Why?
Alopecia
1
2019
38
0.140
Why?
Recombinant Fusion Proteins
1
2019
175
0.140
Why?
Fibrin Fibrinogen Degradation Products
1
2018
9
0.140
Why?
Fibrinogen
1
2018
33
0.140
Why?
Bilirubin
3
2015
43
0.140
Why?
Thrombocytopenia
1
2019
89
0.140
Why?
Autoimmune Diseases
1
2019
90
0.130
Why?
Quality of Life
2
2025
902
0.130
Why?
Follow-Up Studies
2
2021
2318
0.120
Why?
Aged
5
2024
10430
0.110
Why?
Hydroxyurea
1
2015
29
0.110
Why?
Ankyrins
1
2014
9
0.110
Why?
Prevalence
2
2024
1034
0.110
Why?
Acute Chest Syndrome
1
2014
7
0.110
Why?
Diagnosis, Differential
1
2018
1038
0.110
Why?
Respiratory Tract Infections
1
2014
82
0.100
Why?
Iron-Dextran Complex
1
2013
3
0.100
Why?
Hematoma
1
2013
67
0.090
Why?
Protein Precursors
1
2011
42
0.090
Why?
Remission, Spontaneous
1
2011
25
0.090
Why?
Anemia, Hemolytic
1
2011
10
0.090
Why?
Natriuretic Peptide, Brain
1
2011
32
0.090
Why?
Tricuspid Valve
1
2011
23
0.090
Why?
Texas
1
2011
138
0.080
Why?
Early Diagnosis
1
2011
84
0.080
Why?
Glucaric Acid
1
2010
2
0.080
Why?
Infant, Newborn
3
2024
2913
0.080
Why?
Blood Cell Count
1
2010
36
0.080
Why?
Cholesterol, LDL
1
2010
42
0.080
Why?
Aged, 80 and over
2
2024
3495
0.080
Why?
C-Reactive Protein
1
2010
152
0.080
Why?
Ultrasonography
1
2011
426
0.080
Why?
Lipids
1
2010
163
0.080
Why?
Neoplasms
1
2019
1335
0.070
Why?
Medical Audit
1
2008
20
0.070
Why?
Time Factors
3
2024
2992
0.070
Why?
United States
3
2025
5413
0.060
Why?
Cholesterol
1
2007
161
0.060
Why?
Rho(D) Immune Globulin
1
2025
3
0.060
Why?
Acute Disease
1
2006
393
0.060
Why?
Health Care Surveys
1
2025
182
0.060
Why?
Immunoglobulins, Intravenous
1
2025
64
0.060
Why?
Resilience, Psychological
1
2025
34
0.050
Why?
Terminology as Topic
1
2024
72
0.050
Why?
Vincristine
1
2023
89
0.050
Why?
Glucocorticoids
1
2025
236
0.050
Why?
Motivation
1
2025
287
0.050
Why?
Disease Management
1
2024
187
0.050
Why?
Ambulatory Care Facilities
1
2023
121
0.050
Why?
Clinical Competence
1
2025
406
0.050
Why?
Genetic Vectors
1
2023
127
0.050
Why?
Alleles
1
2023
277
0.050
Why?
Genetic Testing
1
2023
130
0.050
Why?
Sclerosing Solutions
1
2022
16
0.050
Why?
Educational Status
1
2023
229
0.040
Why?
Registries
2
2015
652
0.040
Why?
P-Selectin
1
2021
27
0.040
Why?
Emergency Service, Hospital
1
2025
530
0.040
Why?
Analgesics
1
2021
104
0.040
Why?
Pain Measurement
1
2021
259
0.040
Why?
Intensive Care Units, Pediatric
1
2020
158
0.040
Why?
Arkansas
1
2025
2068
0.040
Why?
Clinical Trials as Topic
1
2021
466
0.040
Why?
Disease Susceptibility
1
2019
96
0.040
Why?
Incidence
1
2021
1085
0.030
Why?
Disease-Free Survival
1
2019
466
0.030
Why?
Length of Stay
1
2020
684
0.030
Why?
Survival Rate
1
2019
949
0.030
Why?
Immunosuppressive Agents
1
2018
253
0.030
Why?
Therapeutic Equivalency
1
2015
9
0.030
Why?
Solutions
1
2015
24
0.030
Why?
Capsules
1
2015
29
0.030
Why?
Antisickling Agents
1
2015
14
0.030
Why?
Decision Making
1
2018
278
0.030
Why?
Reticulocytes
1
2014
9
0.030
Why?
Physicians
1
2018
242
0.030
Why?
Risk Assessment
1
2019
1368
0.030
Why?
Forehead
1
2013
8
0.020
Why?
Laparoscopy
1
2015
180
0.020
Why?
Molecular Weight
1
2013
77
0.020
Why?
Syndrome
1
2011
248
0.020
Why?
Hemolysis
1
2009
28
0.020
Why?
Thrombocytosis
1
2007
6
0.020
Why?
Polycythemia
1
2007
10
0.020
Why?
Wounds and Injuries
1
2009
301
0.010
Why?
Crary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description